{
    "organizations": [],
    "uuid": "a859874030310bc5b690892e7fef3812bc5b4345",
    "author": "",
    "url": "https://www.reuters.com/article/brief-aveo-reports-q1-loss-per-share-008/brief-aveo-reports-q1-loss-per-share-0-08-idUSASC0A0DQ",
    "ord_in_thread": 0,
    "title": "BRIEF-Aveo Reports Q1 Loss Per Share $0.08",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "May 8, 2018 / 11:20 AM / Updated 13 minutes ago BRIEF-Aveo Reports Q1 Loss Per Share $0.08 Reuters Staff\nMay 8 (Reuters) - Aveo Pharmaceuticals Inc:\n* AVEO REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE * Q1 REVENUE $1.0 MILLION VERSUS $2.5 MILLION\n* Q1 EARNINGS PER SHARE VIEW $-0.07 â€” THOMSON REUTERS I/B/E/S\n* BELIEVE THAT $27.0 MILLION IN CASH RESOURCES WOULD ALLOW US TO FUND OUR PLANNED OPERATIONS INTO Q1 OF 2019 Source text for Eikon: Further company coverage:",
    "published": "2018-05-08T14:15:00.000+03:00",
    "crawled": "2018-05-08T14:36:05.029+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "may",
        "updated",
        "minute",
        "ago",
        "report",
        "q1",
        "loss",
        "per",
        "share",
        "reuters",
        "staff",
        "may",
        "reuters",
        "aveo",
        "pharmaceutical",
        "inc",
        "aveo",
        "report",
        "first",
        "quarter",
        "financial",
        "result",
        "provides",
        "business",
        "update",
        "q1",
        "revenue",
        "million",
        "versus",
        "million",
        "q1",
        "earnings",
        "per",
        "share",
        "view",
        "thomson",
        "reuters",
        "believe",
        "million",
        "cash",
        "resource",
        "would",
        "allow",
        "u",
        "fund",
        "planned",
        "operation",
        "q1",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}